EZZ Life Science (EZZ) Stock Price, News & Analysis

Company Overview

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand. The company also offers its products online. EZZ Life Science Holdings Limited was incorporated in 2015 and is based in Silverwater, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 0.57%
• Price Target: N/A
• Consensus Rating: N/A

EZZ Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of EZZ Life Science own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EZZ Life Science investors own include Allied Gaming & Entertainment (AGAE), AGL Energy (AGL), AMP (AMP), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO) and Berkeley Energia (BKY).

Company Calendar

• Ex-Dividend for 12/8 Dividend: 11/04/2024
• Dividend Payable: 12/08/2024
• Today: 1/15/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: ASX:EZZ
• CUSIP: N/A
• CIK: N/A
• Web: ezzlife.com.au
• Phone: 61 2 9160 2305
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A$0.08
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $6.96 million
• Net Margins: 10.48%
• Pretax Margin: N/A
• Return on Equity: 38.79%
• Return on Assets: 28.12%

Debt

• Debt-to-Equity Ratio: 0.58
• Current Ratio: 5.96
• Quick Ratio: 4.53

Sales & Book Value

• Annual Sales: $66.44 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.48 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 44,420,000
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.47